Navigation Links
Benicar Lawsuit Page Launched by Wright & Schulte LLC to Provide Updated Information on Benicar Side Effects, Growing Litigation
Date:7/19/2014

Columbus, OH (PRWEB) July 19, 2014

A Benicar lawsuit webpage has been launched by Wright & Schulte LLC to provide consumers with important information regarding a serious gastrointestinal disorder called sprue-like enteropathy that can sometimes accompany use of the high blood pressure medication. The new Benicar lawsuit webpage will also be updated on a regular basis with information about the growing Benicar litigation in U.S. courts. Wright & Schulte LLC is now offering free legal evaluations to anyone who may have experienced serious gastrointestinal problems while using Benicar, including:

  • Chronic diarrhea
  • Severe, rapid weight loss
  • Dehydration
  • Vomiting
•Inflammation of the intestines

Benicar, known generically as olmesartan, was brought to market by Daiichi Sankyo in 2002. It is one of a class of high blood pressure medications known as angiotensin receptor blockers, or ARBS. In 2012, a study published in Mayo Clinic Proceedings reported that a number of patients using olmesartan had developed gastrointestinal problems similar to those associated with celiac disease. The symptoms disappeared once the patients had stopped using the medication, which strongly suggested a link between olmesartan and their problems.
[mayoclinicproceedings.org/article/S0025-6196%2812%2900558-7/fulltext, Mayo Clinic Proceedings, June 2012]

A little more than a year later, the FDA issued a public health alert stating that it there was “clear evidence of an association between olmesartan” and the development of sprue-like enteropathy. The agency ordered the manufacturers of Benicar and other forms of olmesartan, including Benicar HCT, Azor, and Tribenzor, to modify the product labels to include information about this potential side effect. The FDA also advised doctors to discontinue treatment with olmesartan in patients who exhibited symptoms of sprue-like enteropathy.
[fda.gov/drugs/drugsafety/ucm359477.htm, FDA, July 2013]

Since the FDA issued its alert last July, a growing number of Benicar lawsuits have been filed in U.S. courts on behalf of patients who allegedly developed sprue-like enteropathy due to the medication. This past March, for example, a Texas man filed a Benicar lawsuit in New Jersey’s Atlantic County Superior Court, alleging his use of the medication caused chronic diarrhea, dehydration, weight loss, nausea, vomiting and malnutrition over a period of several years. Because his doctors were unaware of the association between Benicar and severe gastrointestinal problems, the plaintiff was hospitalized for more than 100 days over a four year period, as his health care providers tried to determine the cause of his problems. (Docket No. Docket No. ATL-L-506-14)

The attorneys of Wright & Schulte LLC believe that additional Benicar lawsuits involving similar allegations will be filed against the manufacturer of this medication in the coming months. The Firm is offering free, no-obligation legal reviews to anyone who suffered severe gastrointestinal problems that may be associated with Benicar. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Benicar lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12023364.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Flood Law Group to Sponsor BenicarLawsuits.org
2. Stryker Recall Litigation in New Jersey Now Includes More than 2,000 Lawsuits over Rejuvenate, ABG II Metal Hips, Bernstein Liebhard LLP Reports
3. Testosterone Lawsuit News: Bernstein Liebhard LLP Notes Recent Study Finding Dramatic Rise in Canadian Men Taking Hormone Therapy Treatments
4. Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
5. Bernstein Liebhard LLP Launches New Xarelto Lawsuit Website for Individuals Allegedly Injured by Blood Thinner
6. Testosterone Treatment Lawsuit: Bernstein Liebhard LLP Notes Health Canada Alert on Possible Association Between Low Testosterone Therapy, Cardiovascular Problems
7. Mirena IUD Lawsuit Allowed to Proceed in State Court, After Judge Rules Certain Healthcare Defendants Weren’t Misjoined, Bernstein Liebhard LLP Reports
8. LawyersandSettlements.com Interviews Attorney Roy Pollack About The Recent Microsoft Wrongful Termination Lawsuit Decision for the Plaintiff in Texas
9. Stryker Hip Lawsuit News: Florida Stryker Hip Recall Plaintiffs Seek Adverse Event Data on Similar Products, Bernstein Liebhard LLP Reports
10. Federal Judge Overseeing Ethicon Vaginal Mesh Lawsuit Denies Summary Judgment on Certain Claims, Bernstein Liebhard LLP Reports
11. Transvaginal Mesh Lawsuit News: Federal Plaintiff Allowed to Pursue Claims Related to Use of Prolene in Ethicon Mesh Products, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical ... to studying to become a nun. Now, she writes about God, when she isn’t swimming ... Know BC and AD, Here is BS! (Before Satan),” she offers a comedic look at ...
(Date:2/27/2017)... N. Y. (PRWEB) , ... February 27, 2017 , ... ... ( ILADS ) has disclosed that despite scientific studies, the Center for Disease Control ... chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an extension of ... to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite ... globally recognised standard that sets out requirements for the technical competence of testing ...
(Date:2/26/2017)... (PRWEB) , ... February 26, ... ... sets a new technology standard in staffing, scheduling, and reporting for healthcare ... and predict activity throughout the entire staffing process. StaffBridge technology improves staffing ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology: